Aluna

What Aluna does

Aluna, founded in 2016 by Charvi Shetty and Inderjit Jutla, develops an FDA-cleared at-home digital spirometer paired with a Bluetooth-connected mobile application for monitoring chronic respiratory conditions including asthma, COPD, and cystic fibrosis. The core technology combines a differential pressure sensor with proprietary machine learning algorithms co-developed with pulmonologists, enabling hospital-grade accuracy, automatic detection of adequate versus inadequate test effort, BTPS environmental corrections, and real-time FEV1% trend analysis with flow-volume curves. Clinical validation was performed against the nSpire Koko clinical standard, and the platform is supported by an NSF STTR Phase II award and partnerships with UCSF, Children's Hospital Los Angeles, and the University of Vermont.

The company operates a hybrid go-to-market selling hardware devices directly to consumers via its e-commerce site (alunacare.com), to healthcare providers for telemedicine-enabled remote patient monitoring (with CPT code billing support), and to clinical research organizations for at-home spirometry data collection in respiratory trials. Revenue derives from device sales, recurring app subscriptions processed through Stripe and the Apple App Store, and clinical trial services, with the product available only in the United States. In May 2025, Aluna was acquired by Huma Therapeutics as part of a strategic partnership with Eckuity Capital, integrating its respiratory monitoring platform into Huma's cloud-based digital health ecosystem.

Name

Aluna

Legal name

Huma Therapeutics Inc

Website

http://www.alunacare.com

Company type

Private

Founded year

2016

Operating status

Acquired

Headcount range

1–10 employees

Short description

Aluna builds an FDA-cleared at-home digital spirometer and companion mobile app that enables patients with asthma, COPD, and cystic fibrosis, along with their healthcare providers and clinical researchers, to monitor lung function remotely with hospital-grade accuracy.

Ownership category

akta.pro rank

Product category

Digital Respiratory Monitoring Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Pulmonary Function Testing (PFT) & Spirometry Equipment (HLAHAGAH)

akta.pro secondary industries

Blood Oxygen & Respiratory Monitoring (Pulse Oximetry, Capnography, Spirometry) (HLAHACAD), Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK), Pulmonology & Sleep Medicine Telemedicine Platforms (HLALAGAF), Pulse Oximeters & Respiratory Monitors (Consumer) (CRACAQAF), eCOA/ePRO/eDiary & Patient-Facing Data Collection (HLACAOAB)

Keywords

• Digital spirometer device
• Lung health monitoring
• Respiratory care platform
• At-home spirometry
• Telemedicine spirometry

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

1. Hardware Device Sales: Aluna sells its digital spirometer device directly to consumers and healthcare providers. The device is available for both OTC and prescription use.
2. Subscription Services: The company offers subscription services for app features and data storage. Payment processing through Stripe and Apple App Store indicates recurring billing capability.
3. Clinical Trial Services: Aluna provides spirometry monitoring solutions for clinical research, supporting pharmaceutical companies and research organizations conducting respiratory disease studies.
4. Provider Dashboard and Telemedicine: Healthcare providers use Aluna's dashboard for patient monitoring, time tracking, and billing against CPT codes for reimbursement purposes.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

Aluna sells an FDA-cleared portable digital spirometer hardware device paired with a Bluetooth-connected iOS/Android mobile app that tracks FEV1%, symptoms, medication, and environmental factors for at-home lung health monitoring. The platform serves patients with asthma, COPD, and cystic fibrosis, and additionally offers a Provider Dashboard for remote patient monitoring and clinical trial data collection services for research organizations.

Product overview

Aluna is a lung health management platform centered around an FDA-cleared digital spirometer system. The core offering consists of the Aluna Device (hardware spirometer) paired with the Aluna Mobile App, providing at-home lung function monitoring for asthma and cystic fibrosis patients. The Aluna Provider Dashboard enables healthcare providers to remotely monitor patients, while the Clinical Trial Platform supports respiratory health research. In 2025, Aluna was acquired by Huma Therapeutics and integrated into the Huma Cloud Platform, expanding its global digital health ecosystem capabilities.

Differentiator

Problem solved

Functional benefit

Products and services

• Aluna Digital Spirometer Device FDA-cleared portable digital spirometer hardware device that measures lung function including FEV1% predicted, PEFR, and flow-volume curves. Connects via Bluetooth to the companion mobile app, features a removable mouthpiece, USB charging, and hospital-grade accuracy. FDA-cleared for both over-the-counter and prescription use, for kids and adults.
• Aluna Mobile App Companion mobile application for iOS and Android that connects to the Aluna spirometer device via Bluetooth and tracks symptoms, medication usage, environmental factors, exercise, and lung health data over time. Includes gamification (games, challenges, gems, ship parts, quests, rewards), real-time FEV1% lung health monitoring, and the ability to share data with healthcare providers.
• Aluna Provider Dashboard Web-based portal for healthcare providers (physicians, pulmonologists, allergists) to remotely monitor patients' lung health data, track medication adherence, receive automatic alerts for at-risk patients, and manage telemedicine workflows. Includes time tracking for CPT-code billing/reimbursement and patient data export capabilities.
• Aluna Clinical Trial Platform Clinical research service providing portable spirometry data collection for pharmaceutical companies and research organizations conducting respiratory disease trials. Enables remote participant monitoring (ages 5+), real-time access to respiratory function data (FEV1%, PEFR, flow-volume loops), and automatic flagging of at-risk participants.

Quantifiable outcome

• 10x increase in patient base in 2022
• +2 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature6 records

Partnerships

Five partnerships are on record, tiered major and core.

• Huma TherapeuticsmajorOthersIn May 2025, Huma Therapeutics acquired Aluna to expand its digital health ecosystem and respiratory health capabilities. Aluna's respiratory monitoring solutions are being integrated into Huma's cloud platform.
• National Science Foundation (NSF)coreStrategic or Co-development PartnerNSF awarded grant funding for development of respiratory management tool. Award #1738560 - STTR Phase II focused on User-Friendly Spirometer and Mobile App for Self-Management and Home Monitoring of Asthma Patients.
• UCSF (University of California, San Francisco)coreStrategic or Co-development PartnerAcademic research partner. Aluna's data may be used as part of a UCSF study on asthma and spirometry. Logo partner on the website.
• Children's Hospital Los AngelescoreStrategic or Co-development PartnerClinical validation partner. Logo displayed on Aluna's website indicating partnership in research and validation of the spirometry platform.
• University of VermontcoreStrategic or Co-development PartnerAcademic research partner. Logo displayed on Aluna's website indicating partnership.

Scale indicators4 records

Expansion highlights5 records

Direct peers

• NuvoAir: NuvoAir offers a connected at-home spirometer and digital respiratory care platform for asthma, COPD, and CF patients, with provider dashboards and clinical trial services. It is the closest direct competitor to Aluna in the consumer + provider + clinical trial respiratory digital health category.
• Vitalograph: Vitalograph is a long-standing manufacturer of clinical-grade spirometers and respiratory diagnostic devices used in healthcare and clinical research. It is a direct peer in the spirometry hardware category, with deeper hospital/clinic penetration than Aluna.
• nSpire Health: nSpire Health produces the Koko spirometer, the clinical reference device against which Aluna validated its algorithm. It is a direct peer in PFT/spirometry equipment serving providers and clinical trials.
• MIR (Medical International Research): MIR manufactures portable and clinical spirometers used by physicians, occupational health, and clinical trials globally. It is a direct peer in the spirometry hardware category, with established international distribution.

Broad incumbents

• Propeller Health (ResMed): Propeller Health, acquired by ResMed, is a digital therapeutics platform focused on respiratory medication adherence and symptom tracking for asthma and COPD. It is a broad incumbent in connected respiratory monitoring with deeper payor and provider integrations than Aluna.
• ResMed: ResMed is a global leader in sleep and respiratory care devices (CPAP, ventilators) and the parent of Propeller Health. It is a broad incumbent in the respiratory device space with the scale and payor relationships that dwarf Aluna's.
• Philips Respironics: Philips Respironics is a major incumbent in respiratory care, offering a portfolio of ventilators, sleep, and connected monitoring solutions. It is a broad incumbent that competes for the same pulmonology provider and health system budgets as Aluna.

Emerging players

• Adherium: Adherium develops connected inhaler sensors and digital respiratory monitoring solutions for asthma and COPD. It overlaps with Aluna in the remote respiratory monitoring space but focuses on inhaler adherence rather than at-home spirometry.
• Cohero Health: Cohero Health builds connected respiratory devices and a digital platform tracking lung function and medication adherence for asthma and COPD patients. It overlaps with Aluna in the consumer + provider remote monitoring category.
• Resmirio (Smart Respiratory): Smart Respiratory produces connected spirometers and patient-facing apps for at-home lung function monitoring. It is an emerging peer with product overlap to Aluna in the home spirometry and remote patient monitoring category.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/alunacare
• Facebookfacebook.com/alunacare
• Instagraminstagram.com/alunacare
• LinkedInlinkedin.com/company/alunacare

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds12 records

Investors11 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aluna